Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NNAVW
1251
DELISTED
NextNav Inc Warrant
NNAVW
| $14.1M | ﹤0.01% |
4,850,005
+270,183
| +6% | +$758K |
|
1252
Bio-Rad Laboratories Class A
BIO
$9.16B
| $14M | ﹤0.01% |
41,976
-5,406
| -11% | -$1.72M |
|
1253
BHP
BHP
$223B
| $14M | ﹤0.01% |
226,083
+109,337
| +94% | +$6.04M |
|
1254
CALL
Abercrombie & Fitch
ANF
$4.91B
| $14M | ﹤0.01% |
+100,000
| New | +$15.2M |
|
|
LINE
1255
Lineage Inc
LINE
$9.25B
| $13.9M | ﹤0.01% |
+177,703
| New | +$14.9M |
|
1256
PUT
Crocs
CROX
$6.43B
| $13.9M | ﹤0.01% |
+96,000
| New | +$13.1M |
|
1257
Webster Financial
WBS
$12.8B
| $13.9M | ﹤0.01% |
297,834
+79,556
| +36% | +$3.65M |
|
1258
Core Scientific
CORZ
$6.76B
| $13.9M | ﹤0.01% |
1,170,090
+433,855
| +59% | +$4.5M |
|
1259
BridgeBio Pharma
BBIO
$16.2B
| $13.9M | ﹤0.01% |
545,008
+131,743
| +32% | +$3.46M |
|
1260
Lantheus
LNTH
$6.6B
| $13.8M | ﹤0.01% |
126,016
+86,414
| +218% | +$8.98M |
|
1261
Unity
U
$18B
| $13.8M | ﹤0.01% |
610,122
+105,479
| +21% | +$1.82M |
|
|
1262
CALL
Texas Instruments
TXN
$254B
| $13.8M | ﹤0.01% |
66,600
-3,400
| -5% | -$683K |
|
1263
Ralph Lauren
RL
$23.6B
| $13.7M | ﹤0.01% |
70,823
-1,584
| -2% | -$274K |
|
|
DNB
1264
DELISTED
Dun & Bradstreet
DNB
| $13.7M | ﹤0.01% |
1,192,700
+705,707
| +145% | +$7.84M |
|
1265
Nu Holdings
NU
$68.2B
| $13.7M | ﹤0.01% |
1,005,022
+359,733
| +56% | +$4.84M |
|
1266
PUT
VF Corp
VFC
$5.8B
| $13.7M | ﹤0.01% |
+687,300
| New | +$11.5M |
|
1267
HealthEquity
HQY
$8.65B
| $13.6M | ﹤0.01% |
166,492
+112,667
| +209% | +$8.69M |
|
1268
10x Genomics
TXG
$5.79B
| $13.6M | ﹤0.01% |
602,536
+80,579
| +15% | +$1.67M |
|
1269
Affiliated Managers Group
AMG
$9.83B
| $13.6M | ﹤0.01% |
76,488
+55,302
| +261% | +$9.39M |
|
1270
XPO
XPO
$23B
| $13.6M | ﹤0.01% |
126,468
-177,805
| -58% | -$19.9M |
|
1271
Essential Utilities
WTRG
$11.3B
| $13.6M | ﹤0.01% |
352,021
-30,930
| -8% | -$1.22M |
|
1272
CALL
Super Micro Computer
SMCI
$19B
| $13.6M | ﹤0.01% |
326,000
+161,000
| +98% | +$9.8M |
|
1273
Federal Signal
FSS
$7.8B
| $13.6M | ﹤0.01% |
145,188
+112,092
| +339% | +$10.2M |
|
1274
Powell Industries
POWL
$7.55B
| $13.5M | ﹤0.01% |
182,907
+121,545
| +198% | +$6.62M |
|
1275
PUT
Novartis
NVS
$293B
| $13.5M | ﹤0.01% |
+117,600
| New | +$13.3M |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.